Henry Schein's CEO noted margin pressures from pricing and promotions, while the CFO reiterated H2 earnings expectations.
3 reports, 2 independent
Updated Aug 13
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 3
- Developments
- 2
- Repetition
- 33%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Henry Schein's CEO noted margin pressures from pricing and promotions, while the CFO reiterated H2 earnings expectations.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Henry Schein reports margin pressures and reiterates H2 earnings guidance.1 source
Tariffs are causing lower sales for Henry Schein in the United States.1 source
Keep exploring
The entities involved
-
Henry Schein
American distributor of health care products and services
Coverage
Newest first; wire copies grouped- StockStoryHSIC Q2 Deep Dive: Margin Pressures Persist Despite Solid Revenue, New Initiatives Announced Dental and medical products company Henry Schein (NASDAQ:HSIC) met Wall Street’s revenue expectations in Q
- StockStoryWhy Henry Schein (HSIC) Shares Are Falling Today Shares of dental and medical products company Henry Schein (NASDAQ:HSIC) fell 9.7% in the afternoon session after the company reported second-quarter
- ZacksHenry Schein Stock Falls on Q2 Earnings Miss, Revenues Top Henry Schein, Inc. HSIC registered second-quarter 2025 adjusted earnings per share (EPS) of $1.10, down 10.6% from the year-ago period’s fig